UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

History, background, concepts and current use of comedication and polypharmacy in psychiatry

The International Journal of Neuropsychopharmacology, 2014-07, Vol.17 (7), p.983-996

2014

Volltextzugriff (PDF)

Flupentixol use and adverse reactions in comparison with other common first- and second-generation antipsychotics: data from the AMSP study

European archives of psychiatry and clinical neuroscience, 2014-03, Vol.264 (2), p.131-141

2014

Volltextzugriff (PDF)

Validation of amyloid-β peptides in CSF diagnosis of neurodegenerative dementias

Molecular psychiatry, 2007-07, Vol.12 (7), p.671-680

2007

Volltextzugriff (PDF)

Evaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression Scale

Acta psychiatrica Scandinavica, 2011-03, Vol.123 (3), p.228-238

2011

Volltextzugriff (PDF)

CSF diagnosis of Alzheimer's disease and dementia with Lewy bodies

Journal of Neural Transmission, 2006-11, Vol.113 (11), p.1771-1778

2006

Volltextzugriff (PDF)

A novel MRI-biomarker candidate for Alzheimer's disease composed of regional brain volume and perfusion variables

European journal of neurology, 2010-12, Vol.17 (12), p.1437-1444

2010

Volltextzugriff (PDF)

Outcome of suicidal patients with schizophrenia: results from a naturalistic study

Acta psychiatrica Scandinavica, 2010-05, Vol.121 (5), p.359-370

2010

Volltextzugriff (PDF)

A 28-week, double-blind, placebo-controlled study with Cerebrolysin in patients with mild to moderate Alzheimer's disease

International clinical psychopharmacology, 2001-09, Vol.16 (5), p.253-263

2001

Volltextzugriff (PDF)

Sustained improvements in patients with dementia of Alzheimer's type (DAT) 6 months after termination of Cerebrolysin therapy

Journal of Neural Transmission, 2000-01, Vol.107 (7), p.815-829

2000

Volltextzugriff (PDF)

Assessment of Psychosocial Functioning in a Large Cohort of Patients with Schizophrenia

Psychiatric quarterly, 2021-03, Vol.92 (1), p.177-191

2021

Volltextzugriff (PDF)

Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin

Molecular psychiatry, 2007-02, Vol.12 (2), p.206-220

2007

Volltextzugriff (PDF)

Amyloid β peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing

Experimental neurology, 2010-06, Vol.223 (2), p.366-370

2010

Volltextzugriff (PDF)

Pharmacological validation of a chronic social stress model of depression in rats: effects of reboxetine, haloperidol and diazepam

Behavioural pharmacology, 2008-05, Vol.19 (3), p.183-196

2008

Volltextzugriff (PDF)

Seizures during antidepressant treatment in psychiatric inpatients—results from the transnational pharmacovigilance project “Arzneimittelsicherheit in der Psychiatrie” (AMSP) 1993–2008

Psychopharmacology, 2013-11, Vol.230 (2), p.191-201

2013

Volltextzugriff (PDF)

What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder?

European psychiatry, 2015-01, Vol.30 (1), p.43-50

2015

Volltextzugriff (PDF)

combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI

The Journal of nutrition, health & aging, 2012, Vol.16 (6), p.544-548

2012

Volltextzugriff (PDF)

Insight in schizophrenia–course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorder

European psychiatry, 2012-11, Vol.27 (8), p.625-633

2012

Volltextzugriff (PDF)

The AMSP drug safety program: methods and global results

Pharmacopsychiatry, 2004-03, Vol.37 Suppl 1, p.S4-11

2004

Volltextzugriff (PDF)

Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome

Journal of Neural Transmission, 2006-02, Vol.113 (2), p.239-254

2006

Volltextzugriff (PDF)

Sustained improvement of cognition and global function in patients with moderately severe Alzheimer's disease: a double-blind, placebo-controlled study with the neurotrophic agent Cerebrolysin

Journal of neural transmission. Supplementum, 2002 (62), p.265

2002

Volltextzugriff (PDF)

Elevation of beta-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells

The Journal of biological chemistry, 2001-11, Vol.276 (46), p.42645-42657

2001

Volltextzugriff (PDF)

Improved sleep continuity and increased slow wave sleep and REM latency during ziprasidone treatment: a randomized, controlled, crossover trial of 12 healthy male subjects

The journal of clinical psychiatry, 2005-08, Vol.66 (8), p.989-996

2005

Volltextzugriff (PDF)

Assessment of benefits of drug therapies: memantine for Alzheimer's disease as an example

Fortschritte der Neurologie-Psychiatrie, 2012-12, Vol.80 (12), p.694

2012

Volltextzugriff (PDF)

Time course of antipsychotic treatment response in schizophrenia: Results from a naturalistic study in 280 patients

Schizophrenia research, 2010-05, Vol.118 (1), p.183-188

2010

Volltextzugriff (PDF)

1 – 25 von 211

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(171)
Mit Volltextzugriff
(134)

Publikationsform

Artikel
(211)

Sprache

Englisch
(148)
Deutsch
(63)

Erscheinungsjahr

n.n

Thema

Humans
(178)
Science & Technology
(149)
Life Sciences & Biomedicine
(146)
Male
(103)
Female
(101)
Adult
(69)
Biological And Medical Sciences
(69)
Middle Aged
(58)
Medical Sciences
(54)
Animals
(47)
Neurosciences & Neurology
(46)
Aged
(38)
Psychiatry
(38)
Neurosciences
(36)
Mice
(32)
Adolescent
(25)
Clinical Neurology
(24)
Biochemistry & Molecular Biology
(22)
Psychology. Psychoanalysis. Psychiatry
(21)
Fundamental And Applied Biological Sciences. Psychology
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

History, background, concepts and current use of comedication and polypharmacy in psychiatry

Flupentixol use and adverse reactions in comparison with other common first- and second-generation antipsychotics: data from the AMSP study

Validation of amyloid-β peptides in CSF diagnosis of neurodegenerative dementias

Evaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression Scale

CSF diagnosis of Alzheimer's disease and dementia with Lewy bodies

A novel MRI-biomarker candidate for Alzheimer's disease composed of regional brain volume and perfusion variables

Outcome of suicidal patients with schizophrenia: results from a naturalistic study

A 28-week, double-blind, placebo-controlled study with Cerebrolysin in patients with mild to moderate Alzheimer's disease

Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment

Sustained improvements in patients with dementia of Alzheimer's type (DAT) 6 months after termination of Cerebrolysin therapy

Assessment of Psychosocial Functioning in a Large Cohort of Patients with Schizophrenia

Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin

Amyloid β peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing

Pharmacological validation of a chronic social stress model of depression in rats: effects of reboxetine, haloperidol and diazepam

Seizures during antidepressant treatment in psychiatric inpatients—results from the transnational pharmacovigilance project “Arzneimittelsicherheit in der Psychiatrie” (AMSP) 1993–2008

What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder?

combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI

Insight in schizophrenia–course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorder

The AMSP drug safety program: methods and global results

Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome

Sustained improvement of cognition and global function in patients with moderately severe Alzheimer's disease: a double-blind, placebo-controlled study with the neurotrophic agent Cerebrolysin

Elevation of beta-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells

Improved sleep continuity and increased slow wave sleep and REM latency during ziprasidone treatment: a randomized, controlled, crossover trial of 12 healthy male subjects

Assessment of benefits of drug therapies: memantine for Alzheimer's disease as an example

Time course of antipsychotic treatment response in schizophrenia: Results from a naturalistic study in 280 patients

Aktive Filter

Suchergebnisse filtern